Naveen Modi is the Global Vice Chair of the Intellectual Property group at Paul Hastings, overseeing the firm’s Global Intellectual Property group consisting of more than 100 attorneys. He also serves as the head of the firm’s Patent Office practice.
Mr. Modi’s practice includes all aspects of patent-related work, including litigation (U.S. district court and U.S. International Trade Commission), post-grant proceedings, interferences, client counseling, appeals, and opinions. Having been involved in well over 400 post-grant proceedings, including inter partes review (IPR), post-grant review (PGR), covered business method (CBM) review, and ex parte and inter partes reexamination proceedings, Mr. Modi is one of the foremost experts in challenging and defending patents before the United States Patent and Trademark Office under the America Invents Act, including its Patent Trial and Appeal Board (PTAB). Mr. Modi has been involved in the most number of PTAB proceedings than any other practitioner in the United States.
Mr. Modi has been nationally recognized for his expertise in post-grant proceedings. Chambers USA recognized him as an expert in this area, noting that he “earns effusive praise from clients, who describe him as ‘a brilliant litigator.’ One source reports: ‘Naveen understands all of the rules and subtleties of IPR proceedings better than anyone I've ever worked with.’” Managing Intellectual Property also recognized him as Outstanding IP Litigator of the Year for PTAB. It also named him as an IP Star, noting that he “has developed a significant reputation for his post-grant proceeding practice” and that “[a] top competitor said: ‘Naveen is probably the country’s leader in patent trials before the Patent Trial and Appeal Board. He is simply the most brilliant attorney I’ve worked with.’” One peer added he “would trust him with the crown jewels.” Mr. Modi has been recommended by Legal 500 “for his notable experience in post-grant proceedings.” Law360 has recognized him as a “Legal Lion” and “IP MVP” for his work defending Acorda in the highly publicized IPRs filed by a hedge fund run by Kyle Bass. Financial Times has also “highly commended” his work in connection with these IPRs. Mr. Modi was also recognized as a “Legal Lion” for his work for Boehringer Ingelheim on IPRs where, as Law360 noted, the PTAB “invalidated ‘a key patent’ for AbbVie Inc.’s top selling drug . . . Humira.” In addition Mr. Modi was recognized by Law360 as a “legal lion” for his work for Google. His team successfully obtained four wins at the PTAB, convincing the board to invalidate three of Blackberry Ltd.’s patents related to smartphone technology. Mr. Modi and his team also secured a win for Google and LG Electronics at the Federal Circuit. LMG Life Sciences recognized Mr. Modi as an IP Star in addition to being awarded the Post Grant Proceedings Attorney of the Year at the LMG Life Sciences Awards.
IAM Patent 1000 has recognized Mr. Modi as one of the World’s Leading Patent Professionals. The publication has described the “PTAB Trial Guru’s” deeply impressive personality as “fair, honest, one of the hardest workers and a genteel guy.” Mr. Modi has also been named as one of only six “highly recommended” individuals for post-grant proceedings. IAM Patent 1000 has also previously recognized him as a leading patent practitioner, noting that “[h]e’s just incredibly high quality– a hard worker with a wonderful temperament.’” It noted that “[p]eople think the world of the ‘calm and collected’ Modi, ‘an incredibly thoughtful guy who presents great strategic options tailored to the business goals of his clients.’”
Mr. Modi’s practice encompasses a range of technical areas, including electronics, semiconductor devices, networking, software, business methods, medical devices, and pharmaceuticals.
Mr. Modi teaches courses on appellate practice, including Federal Circuit Practice, at George Mason University School of Law, and he has lectured nationally and internationally in seminars relating to patent procurement and enforcement. Prior to joining Paul Hastings, Mr. Modi was a partner in the Intellectual Property group of an international law firm. He was also a member of the George Mason Law Review and served as a Writing Fellow.
Mr. Modi devotes a portion of his time to serving the bar and pro bono matters. He currently serves as the President for the PTAB Bar Association. He successfully represented an individual in his request for asylum before the Immigration Court.
Paul Hastings Recognized in 2019 Managing Intellectual Property’s IP Stars
June 24, 2019
Paul Hastings Recognized in 2019 IAM Patent 1000 as One of the Most Sophisticated Patent Litigation Practices
June 07, 2019
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2019
May 01, 2019
Paul Hastings Wins Top Honors at 2019 Managing IP Americas Awards
April 08, 2019
Paul Hastings Scores Top Rankings in LMG Life Sciences for 2018
October 11, 2018
Paul Hastings Recognized in 2018 Managing Intellectual Property IP Stars
June 18, 2018
Paul Hastings Recognized in 2018 IAM Patent 1000 For Superb Track Record in Patent Litigation
June 15, 2018
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2018
May 11, 2018
Paul Hastings Wins Law360 Life Sciences Practice Group of the Year
February 05, 2018
Yar Chaikovsky Named Law360 Technology MVP
December 28, 2017
Paul Hastings Recognized in 2017 IAM Patent 1000 for Pristine Patent Litigation Track Record
August 08, 2017
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2017
June 05, 2017
Acorda Therapeutics Wins Four IPRs Across the Board, Defeats Second Hedge Fund Patent Challenge
March 15, 2017
Paul Hastings Intellectual Property Practice Continues Leadership in PTAB Filings
February 09, 2017
Paul Hastings Scores Top Rankings in LMG Life Sciences for 2016
November 30, 2016
Paul Hastings Wins Four LMG Life Sciences Awards
September 16, 2016
Paul Hastings Practices and Lawyers Score Top Rankings in Chambers USA 2016
June 08, 2016
CoreLogic Wins IPRs
May 26, 2016
Naveen Modi Named Outstanding IP Litigator of the Year in PTAB
March 18, 2016
Paul Hastings Leader in PTAB Filings, Naveen Modi Top Overall in Individual Filings
January 07, 2016
Paul Hastings Lawyers Named Law360 IP and Hospitality MVPs
November 13, 2015
Acorda Wins IPRs, Defeating Hedge Fund’s Attempt to Invalidate Drug Patents
August 25, 2015
Nationally Recognized Technology Patent Trial Team Join Paul Hastings in Palo Alto and Washington, D.C.
March 30, 2015
Recognized Patent Litigator Joins Paul Hastings in Washington, DC
June 09, 2014
USPTO Proposes Changing Claim Construction Standard for IPRs, PGRs, and CBMs
May 10, 2018
A Divided Supreme Court Upholds Inter Partes Review’s Constitutionality but Constrains the Patent Office’s Authority
April 25, 2018
PTAB Section 315(b) Time-Bar Determinations Reviewable at the Federal Circuit
January 10, 2018
Aqua Products, Inc. v. Matal: Petitioners Bear the Burden of Establishing the Unpatentability of Amended Claims in IPR Proceedings
October 10, 2017
No Article III Standing Requirement for Appellees in Appeals From IPR Proceedings
August 08, 2017
Prosecution History Disclaimer Extends to IPR Proceedings
May 16, 2017
Paul Hastings Team Secures IPR Trial Win for Zimmer Biomet Holdings, Inc.
March 22, 2017
PTAB Upholds Acorda’s Ampyra® Patents, Rejecting Challenges Based on the Inventors’ Own Work
March 15, 2017
Supreme Court Upholds the BRI Standard and Provides Guidance on Judicial Review
June 23, 2016
Federal Circuit Provides Guidance on the APA’s Procedural Safeguards for PTAB Proceedings
June 16, 2016
More Rule Changes for PTAB Proceedings
April 04, 2016
What Are the Top Five U.S. Litigation Trends for Korean Companies to Follow in 2016?
November 23, 2015
Important Things You Should Know about the Patent Office’s New Guidance Regarding PTAB Proceedings
August 26, 2015
Federal Circuit Rules on Appealability in Post-Grant Proceedings and on What Is a CBM Patent
July 20, 2015
Quick Fixes Implemented, New Rules on the Way for PTAB Trial Practice
April 01, 2015
The Federal Circuit Offers Guidance on Appealability and the Claim Construction Standard in Inter Partes Review Proceedings
February 12, 2015
How can technology companies navigate PTAB's post-grant patent proceedings?
December 10, 2014
Recognized by Chambers USA 2019
Chambers USA 2019: America’s Leading Lawyers for Business listed the firm in 44 practice areas and named 107 firm lawyers to its rankings of leading lawyers and law firms in the United States.
April 26, 2019
Recognized by Managing IP as the Life Sciences IP Litigation Firm of the Year
Paul Hastings was was recognized by Managing IP at their Americas Awards, which honored individuals and companies behind the most innovative and challenging IP work of the past year, as well as those driving the international IP market.
The firm was recognized as Life Sciences IP Litigation Firm of the Year in the United States.
April 05, 2019
Recognized by Managing IP as Outstanding Litigator of the Year – PTAB
Naveen Modi, global vice chair of the Firm’s Intellectual Property Practice, was named Outstanding Litigator of the Year Award: PTAB, an award he also received in 2016. Managing IP noted several of Modi’s wins at the PTAB, including the invalidation of a hip implant patent on behalf of Zimmer Biomet.
April 05, 2019
Recognized as the 2019 Post-Grant Firm of the Year by IAM Magazine
Paul Hastings was recognized as the Post-Grant Firm of the Year at Intellectual Asset Management's inaugural Global IP Awards. The award recognizes the achievements of the firm's Patent Trial and Appeal Board (PTAB) Team, which practices before the US Patent & Trial Office. Over the past year, the team's accomplishments include numerous post-grant proceeding victories for technology and life sciences clients - four of which were affirmed by the Court of Appeals for the Federal Circuit.
January 30, 2019
Recognized as LMG Life Sciences Stars for 2018
Paul Hastings was recognized in the 2018 edition of LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation. LMG Life Sciences selected seven individual lawyers as "Life Sciences Stars," including Eric Dittmann, Gary Giampetruzzi, Naveen Modi, Joseph O’Malley, Chad Peterman, Preston Ratliff, and Bruce Wexler. Earlier this year, LMG Life Sciences honored the firm with the LMG Life Sciences award for Hatch-Waxman Litigation Firm of the Year – Branded.
October 12, 2018
Recognized as the Hatch-Waxman Litigation Firm of the Year by LMG Life Sciences
LMG Life Sciences announced that the firm’s Intellectual Property practice was honored at the LMG Life Sciences Awards as the Hatch-Waxman Litigation Firm of the Year (Branded). The publication cited the firm for wins on behalf of Sunovion Pharmaceuticals, which locked in compound patent protection for Latuda®, the company’s billion-dollar-plus-per-year schizophrenia and bipolar drug, after a judgment of infringement that was affirmed by the Federal Circuit; and for Orexigen Therapeutics after a trial victory where the judge found all three patents-in-suit to be valid and infringed. The firm was also noted for obtaining an unprecedented six walk-away consent judgments in a major pharmaceutical litigation.
The firm and its partners were also shortlisted for:
* Inter-Partes Review Firm of the Year
* Post Grant Proceedings Attorney of the Year: Naveen Modi
* General Patent Litigator of the Year – New York: Bruce Wexler
September 13, 2018
Recognized by Chambers USA 2018
Chambers USA 2018: America’s Leading Lawyers for Business listed the firm in 45 research areas and named 112 firm lawyers to its rankings of leading lawyers and law firms in the United States.
May 15, 2018
Recognized as Law360 Practice Group of the Year in Life Sciences
Paul Hastings was named as a Practice Group of the Year in Life Sciences by Law360. The article noted Paul Hastings’ undefeated track record in life sciences cases at the Patent Trial and Appeal Board, including victories on behalf of Acorda Therapeutics, which won four inter partes reviews against Kyle Bass’ Coalition for Affordable Drugs. Law360 also highlighted the representation of Galena Biopharma in a civil-only settlement resolving investigations regarding Galena’s past promotional practices for Abstral, a rapid onset opioid product. The winners were chosen from nearly 750 submissions, and are recognized as "firms that racked up victories in litigation and closed the big deals to make their mark among clients and throughout the legal industry."
February 01, 2018
Recognized as LMG Life Sciences Stars for 2017
Paul Hastings was recognized in LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation.
LMG Life Sciences selected seven individual lawyers as "Life Sciences Stars," including Joseph O’Malley, Bruce Wexler, Gerald Flattmann, Naveen Modi, Chad Peterman, Eric Dittmann, and Gary Giampetruzzi.
October 06, 2017
Recognized in Patexia's Intelligence Report as the Most Active in Inter Partes Reviews
Patexia acknowledged Naveen Modi as the most active attorney representing petitioners and patent owners in inter partes review (IPR) proceedings at the Patent Trial and Appeal Board (PTAB). Patexia noted that Naveen's workload of 240 cases is the most among the 5,000 attorneys who have worked on IPRs since 2012.
September 19, 2017
Paul Hastings IP Practice Honored in 2017 IAM Patent 1000
Intellectual Asset Management highlighted Paul Hastings' IP practice in IAM Patent 1000: The World's Leading Patent Professionals. The guide ranked the firm's practices Nationwide as well as in New York and Washington, DC. Paul Hastings partners were ranked in California: Yar Chaikovsky; New York: Joseph O'Malley; Gerald Flattmann; Preston Ratliff; Bruce Wexler; Samuel Waxman; Washington DC: Naveen Modi; Blair Jacobs; Joseph Palys; and Allan Soobert; and in Japan: Hiroyuki Hagiwara. Paul Hastings attorneys were also recognized in IAM's Nationwide tables: Yar Chaikovsky and Blair Jacobs were recommended for International Trade Commission litigation; Jacobs was recommended for his experience in Federal Circuit appellate litigation; and Naveen Modi and Joseph Palys were both recognized for their strength in post-grant proceedings. Preston Ratliff was also noted in the IAM Strategy 300, which recognizes individuals for their work in protecting intellectual property as a key business asset.
June 06, 2017
Recognized by Chambers USA 2017
Chambers USA 2017: America’s Leading Lawyers for Business named 46 of the firm’s practice areas and 112 individuals to its ranking of leading lawyers and law firms in the United States.
June 05, 2017
Recognized as LMG Life Sciences Stars for 2016
Paul Hastings was recognized in LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation. LMG Life Sciences selected six individual lawyers as "Life Sciences Stars," including Joseph O’Malley, Bruce Wexler,
Gerald Flattmann, Gary Giampetruzzi, Naveen Modi, and Eric Dittmann.
November 30, 2016
Recognized at the 2016 LMG Life Sciences Awards
Paul Hastings was recognized with multiple LMG Life Sciences Awards. Bruce Wexler was named “General Patent Litigator of the Year – New York” and Naveen Modi was recognized as Post Grant Proceedings Attorney of the Year. The Life Sciences Patent Litigation practice also won awards for two Hatch-Waxman Impact Cases of the Year, including Helsinn Healthcare SA v. Teva Pharmaceuticals USA, a win resolving a long-running patent dispute over Aloxi®, a drug used to treat chemotherapy-induced nausea and vomiting.
The Paul Hastings team representing Helsinn was led by Joseph O’Malley. The firm was also honored for its work on behalf of Eli Lily in Sanofi-Aventis US v. Eli Lilly & Co., where Bruce Wexler led the team representing Eli Lily in litigation regarding the marketing of Basaglar®, its insulin glargine drug product. The case was settled in late 2015, with the press reporting Eli Lilly’s ability to launch the drug.
September 16, 2016
Shortlisted for four LMG Life Sciences Awards for 2016
The Firm was shortlisted in four categories for the LMG Life Sciences Awards. Joseph O’Malley was nominated in the Hatch-Waxman Litigator of the Year – Branded category, Bruce Wexler was nominated in the General Patent Litigator of the Year - New Yorkcategory, Naveen Modi was nominated in the Post Grant Proceedings Attorney of the Year category, and the Firm was nominated in the “Hatch-Waxman Litigation Firm of the Year – Branded” category.
July 27, 2016
Recognized by Chambers USA 2016
Chambers USA 2016: America’s Leading Lawyers for Business named 47 of the firm’s practice areas and 112 individuals to its ranking of leading lawyers and law firms in the United States.
June 08, 2016
Paul Hastings IP Practice Honored in 2016 IAM Patent 1000
Intellectual Asset Management highlighted Paul Hastings' IP practice in its IAM Patent 1000: The World’s Leading Patent Professionals 2016. The guide ranked the firm’s Nationwide, New York, Washington, D.C., and Georgia IP practices; and partners Yar Chaikovsky, Gerald Flattmann, Blair Jacobs, Robin McGrath, Naveen Modi, Joseph O'Malley, Joseph Palys, Preston Ratliff, Samuel Waxman, and Bruce Wexler were recognized as leading lawyers.
May 27, 2016
Managing IP 2016 North America Awards
Naveen Modi was named Outstanding IP Litigator of the Year – PTAB at Managing IP's 2016 North America Awards. Additionally, Paul Hastings was shortlisted in the US Life Sciences IP Litigation Firm of the Year, Patent Contentious Northeast Firm of the Year, and PTAB Firm of the Year categories.
March 18, 2016
Law360 MVP Awards 2015: Intellectual Property
Gerald Flattmann and Naveen Modi were named as MVP award winners by Law360 in the Intellectual Property category. Law360 reviewed more than 850 submissions, selecting attorneys with “successes in high-stakes litigation, record-breaking deals and complex global matters” as this year’s MVP award winners.
November 09, 2015
Paul Hastings IP Practice Honored in 2015 IAM Patent 1000
Intellectual Asset Management highlighted Paul Hastings' IP practice in its IAM
Patent 1000: The World’s Leading Patent Professionals 2015. The guide ranked the firm’s Nationwide, New York, and Washington, D.C. IP practices; and partners Yar Chaikovsky, Gerald Flattmann, Blair Jacobs, Naveen Modi, Joseph O'Malley, Steven Park, Jeff Randall, Preston Ratliff, Allan Soobert, and Bruce Wexler were recognized as leading lawyers.
June 17, 2015
Managing IP's 2015 IP Stars
Yar Chaikovsky, Gerald Flattmann, Blair Jacobs, Chris Kennerly, Naveen Modi, Joseph O'Malley, and Bruce Wexler were named 2015 IP Stars by Managing Intellectual Property magazine. Nationwide, the firm's Intellectual Property practice was ranked in the Bio/Life Sciences, Copyright, and Patent Contentious categories. In New York, the firm was ranked Highly Recommended in the Patent Contentious category, and in California, the firm was ranked Recommended in the Copyright and Patent Contentious categories.
May 15, 2015